ARA-290 (10mg)

99.82% purity · lot 141-01-DK · Jun 15, 2026 ↓

Lab tested 99.82% pure

COA

$50

Only 26 left, order soon.

26 in stock

Quantity	Discount	Price each
2	5%	$47.50
3–4	10%	$45.00
5–9	25%	$37.50
10–26	40%	$30.00

Quick pick

Volume pricing

2 vials5% off

3–4 vials10% off

5–9 vials25% off

10+ vials40% off

Any 10 vials, mixed across the catalog25% off

Your cart

For laboratory research use only. Not for human or veterinary use, not a drug, food, or cosmetic.

Lab record · Freedom Diagnostics

This batch, on the record.

Independently tested, not manufacturer-supplied. Every certificate is verifiable at the lab.

Current batch · Lot 141-01-DKJun 15, 2026

99.82%Purity · HPLC

10.43mgNet content · labeled 10

+4.3%vs labeled

Figures above are the lab's averages across multiple vials pulled from this lot for conformity; every vial is printed on the certificate.

Safety panel · 3 tests

Identity confirmedConfirmed

Fentanyl screenNot detected

Appearance

View certificate Verify at the lab Search code Pept2606120660

How to read it

Purity is the HPLC fraction that is the target peptide. Net content is what the lab weighed against the label, averaged across multiple vials pulled from the lot, with every vial printed on the certificate. For blends each component is reported on its own and the total shown is the sum of those averages. The safety panel is identity, heavy metals, microbial, endotoxin and fentanyl on this production run — not a one-time sample.

Median across our public record: 99.74% · 117 certificates

About ARA-290 (10mg)

EPO-Derived Peptide

ARA-290.

ARA-290 is a synthetic 11-amino-acid peptide derived from the structure of erythropoietin (EPO), studied for tissue-protective signaling without EPO's blood effects.

Class

EPO-derived peptide

Amino acids

Target

Innate repair receptor

Note

No red-cell effect

Innate Repair Receptor

Studied for action on the tissue-protective receptor complex.

Neuropathic Research

Examined in models of small-fiber and neuropathic conditions.

Inflammatory Pathways

Researched for inflammation-modulating signaling.

What It Is

ARA-290 (Cibinetide) is a synthetic peptide modeled on a region of erythropoietin. Unlike EPO itself, it is studied specifically for tissue-protective signaling and does not act on red-blood-cell production.

How It Works

ARA-290 is studied for its action on what researchers call the innate repair receptor — a tissue-protective signaling complex related to, but distinct from, the EPO receptor that drives red-blood-cell production. Research focuses on this protective signaling.

TISSUE-PROTECTIVE PATHWAY

ARA-290→Innate Repair Receptor→Tissue-Protective Signaling

Studied for protective signaling distinct from erythropoietin's blood-cell effects.

Key Points

Synthetic 11-amino-acid EPO-derived peptide
Studied for tissue-protective signaling
Does not act on red-blood-cell production
Researched in neuropathic and inflammatory models

Research Context

ARA-290 has been examined in early human studies for neuropathic conditions and is studied for its tissue-protective rather than blood-related effects.

What's in the Vial

One lyophilized vial containing 10mg of ARA-290 (10mg), supplied for laboratory research use. Reconstitute with bacteriostatic water.

Storage

Lyophilized: store refrigerated, away from light. After reconstitution: keep refrigerated and use within the period indicated on the product label. Do not freeze reconstituted product.

Product Highlights

10mg per vial
EPO-derived peptide
Tissue-protective signaling research
Distinct from blood-cell effects
Lyophilized for shelf stability

For Research Use Only. This product is sold strictly for laboratory and research purposes. It is not approved by the FDA or any regulatory authority for human use, and safety and efficacy in humans have not been established outside of any structured clinical trials referenced. Not for human consumption.